Cargando…
Azithromycin in DuraSite(®) for the treatment of blepharitis
Blepharitis is a common inflammatory disease of the eyelid. Posterior blepharitis affects the posterior lamella of the eyelid and involves inflammation of the meibomian glands, whereas anterior blepharitis affects the anterior lamella of the eyelid and the eyelashes; either version can be inflammato...
Autor principal: | Luchs, Jodi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915852/ https://www.ncbi.nlm.nih.gov/pubmed/20689782 |
Ejemplares similares
-
Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Lichtenstein, Steven J, et al.
Publicado: (2008) -
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite(®) for acute bacterial conjunctivitis
por: McLean, Susannah, et al.
Publicado: (2010) -
An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite(®)
por: Granet, David, et al.
Publicado: (2007) -
Clinical development of 1% azithromycin in DuraSite(®), a topical azalide anti-infective for ocular surface therapy
por: Friedlaender, Mitchell H, et al.
Publicado: (2007) -
Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Friedlaender, Mitchell H, et al.
Publicado: (2008)